TGF Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-13-0207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

Cancers
Cancer ResearchOncology
2020English

HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Evaluating Preclinical Efficacy

Science Translational Medicine
Medicine
2011English

Preclinical Rationale for TGF-β Inhibition as a Therapeutic Target for the Treatment of Myelofibrosis

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

Psychological Stress Enhances Tumor Growth and Diminishes Radiation Response in Preclinical Model of Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Hypofractionated Radiation Therapy for Large Brain Metastases

Frontiers in Oncology
Cancer ResearchOncology
2018English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology
Cancer ResearchOncology
2019English

Decreased NK-cell Tumour Immunosurveillance Consequent to JAK Inhibition Enhances Metastasis in Breast Cancer Models

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy